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Inflammation is a response of the immune system to foreign insult or physical damage. Vari-
ous cellular and humoral components of the immune system are recruited from the vascular
system and are translocated through endothelium, and into extracellular matrix (ECM) com-
partments of inflamed tissues. This translocation is orchestrated by various types of accessory
signals, in the form of soluble or complexed molecules, which evoke remarkable transitions
in leukocyte activities. Recruited inflammatory cells give rise to mechanisms of migration,
including the secretion of enzymes and other pro-inflammatory mediators and the alteration
of their adhesive contacts with the ECM. Hence, migrating cells secrete enzymes, chemok-
ines, and cytokines which interact with the ECM, and thereby, provide the cells with intrinsic
signals for coordinating their responses. Resultant products of enzymatic modifications to the
ECM microenvironment, such as cytokine- and ECM-derived molecules, may be also part of
a cell-signaling mechanism that provides leukocytes with information about the nature of
their inflammatory activity; such a mechanism may give the immune system data that can be
cognitively interpreted for consequential activities. This article reviews the findings that sup-
port this notion and describe the dynamic interactions between participants of the inflamma-
tory processes.
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Abbreviations:ECM, extracellular matrix, HS, heparan sulfate, MMP, matrix metalloproteinase, MIP-1 [,
macrophage inflammatory protein [, RANTES, regulated upon activation normal T cell expressed and
secreted, TIMP, tissue inhibitor of metalloproteinases, TNF, tumor necrosis factor, uPA, urokinase plas-
minogen activator, uPAR, urokinase plasminogen activator receptor
INTRODUCTION
Inflammation is a highly coordinated, localized
immune response to injury or a foreign particle intro-
duced into the body. Most forms of inflammation are
amplified, accelerated and propagated by the recruit-
ment of humoral and cellular components of the
immune system, especially the site-specific accumu-
lation and subsequent activation of leukocytes. Circu-
lating leukocytes are "patrolling" mobile units of the
immune system which facilitate a rapid and efficient
response to tissue insult. While naive lymphocytes
normally migrate into secondary lymphoid tissues
where antigens are presented to invoke differentia-
tion, mature memory and effector lymphocytes dis-
tinctly home to certain sites in the likelihood of
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encountering their specific antigen or context for
effector function. During inflammation, mature lym-
phocytes, primarily memory T cells, extravasate
through blood vessel walls, and migrate through
extracellular matrix (ECM) towards sites of inflam-
mation. These processes require coordination of a
vast array of cellular and molecular mechanisms to
efficiently abate injury, resolve inflammation, and
sustain homeostasis (Springer, 1994; Butcher and
Picker, 1996; Adams and Shaw, 1994).
The ECM, which is made of a tissue-specific varia-
ble mixtures of different types of proteoglycans, glyc-
oproteins, and glycosaminoglycans, has a structural
and mechanical role in supporting and circumscribing
tissue compartments. It serves as a secondary barrier
to the passage of fluids and disseminating cells into
the extravascular compartment (Shimizu and Shaw,
1991). It is becoming increasingly clear that in addi-
tion to its structural importance, the ECM provides
resident or patrolling cells with immunological infor-
mation by sending regulatory messages that promote
cell proliferation, differentiation, activation, and
migration. Thus, the ECM serves as a specialized res-
ervoir of regulatory factors, which may include mac-
romolecules (i.e., collagen type IV, fibronectin,
laminin, heparan sulfate [HS] proteoglycans), pro-
teases and their inhibitors, and cytokines. Changes in
the composition of these factors greatly influence the
outcome of the inflammatory response (Shimizu and
Shaw, 1991; Nathan and Sporn, 1991), as the inflam-
matory microenvironment changes dynamically from
a "latent" form to a modified, "activated" form
thereby promoting inflammatory cell responses. This
transition provides particular subtypes of leukocytes
with contextual information to signal and foster the
appropriate cellular responses, including cell activa-
tion, adhesion, and migration (Gilat et al, 1996). Acti-
vated leukocytes and other cells that constitute the
dynamic microenvironment are also capable of affect-
ing their surroundings. These cells release a wide
range of cytokines, chemokines, growth factors, and
other inflammatory mediators, together with
matrix-degrading enzymes, into the inflammatory
milieu (Madri et al, 1996; Owen and Campbell,
1999). These molecules and their derivatives pre-
sented in the context of the ECM may act reciprocally
to either promote or diminish inflammatory proc-
esses. Recent findings and perspectives of these con-
cepts are presented in this review.
LYMPHOCYTE INTERACTIONS
WITH THE ECM
Lymphocytes recruited into inflamed sites have sen-
sory mechanisms that enable them to process and
cognitively interpret the input data from the "acti-
vated" ECM and to correctly resolve the output
responses. These cellular sensory systems are depend-
ent on membrane receptors that interact with adhesive
ligands and mediate cell-cell and cell-matrix interac-
tions Lymphocyte adhesion to ECM is enhanced
upon cell activation and is crucial not only for
extravasation and migration into inflammation sites,
but also adhesion is linked to the release of cytokines,
growth factors and matrix-degrading enzymes. Lym-
phocytes stimulation by cytokines, chemokines, or
chemical agents, such as phorbol esters, leads to con-
formational changes in cell surface expressed,
ECM-specific ll integrins from low to high affinity
ligand binding states. Thus, integrin-mediated adhe-
sion and de-adhesion resulting from these changes
facilitate cell migration (Hynes, 1992; Shattil and
Ginsberg, 1997; Clark and Brugge, 1995).
The major transducers of signals from the extracel-
lular milieu into lymphocytes are the l integrin fam-
ily of membrane receptors, which is comprised of a
common [ chain (CD29) paired with one of several c
chains. The engagement of integrins with their lig-
ands lead to tyrosine phosphorylation and
integrin-cytoskeleton interactions, resulting in expres-
sion of several genes, such as pro-inflammatory
cytokines and chemokines (Shimizu and Shaw, 1991).
Leukocytes and other cells migrating into the inflam-
matory milieu, including fibroblasts, keratinocytes,
and epithelial cells, may secrete soluble mediators
that bind the ECM. ECM-anchored mediators include
cytokines and chemokines, such as TNF (Alon et al,
1994; Hershkoviz et al, 1995), IFNqt (Lortat et al,
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1997), IL-2 (Ariel et al, 1998), and RANTES and
MIP-1 [ (Gilat et al, 1994), as well as the growth fac-
tors bFGF (Yayon et al, 1991; Bashkin et al, 1989)
and TGF[3 (Yamaguchi et al, 1990). Thus, ECM and
inflammatory mediators may act concomitantly to
transmit synergistic signals to immune cells, such as
lymphocytes, and thereby regulate and restrict
immune reactions to inflammatory loci.
BIOLOGICAL RAMIFICATIONS OF
CYTOKINE INTERACTIONS WITH THE ECM
Cytokines sequestered at sites of inflammation may
be anchored to ECM constituents, thus serving as a
storage depot that affects newly recruited, proximal
leukocytes. A chemoattractant gradient may also be
created in this context, further attracting and activat-
ing incoming leukocytes. In addition, ECM-cytokine
interactions may modulate leukocyte activity to
restricted sites of inflammation. For example, TNFo
which is a key mediator of immune responses, binds
avidly to the major ECM constituents fibronectin
(Alon et al, 1994) and laminin (Hershkoviz et al,
1995). TNFo binding to’fibronectin is mediated by its
30-kDa amino-terminal domain, at a site distinct from
the heparin- and fibrin-binding domains (Alon et al,
1994). This TNFa-fibronectin association augments
[31 integrin-dependent adhesion and increases cellular
protein tyrosine phosphorylation of CD4+ T cells
(Hershkoviz et al, 1994). Moreover, activated lym-
phocytes adhere to fibronectin- or laminin-TNFo sub-
strates more avidly than cells exposed to soluble
TNFo and immobilized fibronectin or laminin sub-
strates (Hershkoviz et al, 1995; Hershkoviz et al,
1994).
Chemokines are low molecular weight molecules
which have important roles in many processes, such
as hematopoiesis, tumor immunology, angiogenesis,
HIV infection, and lymphocyte trafficking (Rollins,
1997; Baggiolini et al, 1997; Ben-Baruch et al, 1995).
Chemokine interactions with cell surface- or
ECM-associated glycosaminoglycans such as HS
(Tanaka et al, 1993; Witt and Lander, 1994), are
important for directing leukocyte migration. Chemok-
ines bind to their G-coupled receptors on leukocytes
and activate a cascade of intracellular signals, includ-
ing augmentation of [land 2 integrin-ligand affini-
ties (Lloyd et al, 1996; Carr et al, 1996). Thus,
ECM-bound chemokines and cytokines amplify the
adhesion of T cells to activated endothelium and
ECM (Taub et al, 1993). Moreover, ECM-bound
chemokines affect the preferential migration of neu-
trophils and T cells by creating haptotactic gradients
of chemoattractants (Taub et al, 1993; Webb et al,
1993; Franitza et al, 1999).
The ECM serves as a scaffold for dynamic proc-
esses, such as cell migration and locomotion, and the
diffusion and binding of factors. The kinetic proper-
ties of these processes were recently analyzed using T
cells migrating in a three-dimensional ECM-like gel
in [’eal-time (Franitza et al, 1999). IL-2 conditioned T
cells embedded in IL-2 and RANTES gradients
formed in ECM gels polarized immediately after
encountering the chemoattractants. Subsequently,
fractions of these cells migrated, in either a random or
directional fashion, towards the chemoattractant
sources, while other cells remained polarized but sta-
tionary. The number of T cells migrating directionally
towards RANTES or IL-2 (which served as key repre-
sentative molecules for chemokines and cytokines,
respectively) peaked in concordance with the forma-
tion of chemotactic gradients. Thus, the kinetics of
gradient-formation affect the migration-related activi-
ties and kinetics of migration. T cell responses to the
matrix-associated chemical gradients probably
involve the modulation of both the composition and
the function of cytoskeletal and signal transducing
elements. Such elements can include GTPases,
GTPase exchange factors, p125FAK, and actin-bind-
ing proteins (Ratner et al, 1997). IL-2R and pertussis
toxin-sensitive receptors mediated the directional
migration of T cells towards IL-2 and RANTES
respectively. The directional and, to a lesser degree,
the random locomotion of T cells induced by both
chemoattractants required intact tyrosine kinase sign-
aling (Franitza et al, 1999). Moreover, preferential
VLA-4 and VLA-5 interactions with fibronectin con-
tributed to the directional migration of T cells, while
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inactive at the physiological pH of 7.2 (Gilat et al,
1995). Thus, heparanase activity is restricted to ana-
tomical sites harboring acidic conditions, such as sites
of inflammation and tumor growth. Interestingly,
heparanase binds to ECM at physiological pH, and
may promote l-integrin-mediated adhesion of CD4+
T cells to ECM. These findings are supported by evi-
dence of increased mobility of IL-2 activated T cells
at pH 6.7 compared to pH 7.1 in ECM gels (Ratner,
1992b), suggesting that increased migration through
ECM may correlate with enhanced activity of hepara-
nase or other degradative enzymes. Moreover,
heparanase-binding to ECM may function similar to
cytokines or chemokines bound to ECM, which facil-
itate the recruitment of cells to inflamed loci. As
inflammatory stimuli arise and the physical condition
of the surroundings change, heparanase exerts its
enzymatic activity.
Supporting this notion was the recent findings
which delineated the enzymatic potential of connec-
tive tissue-activating peptide-III (CTAP-III) (Hoog-
ewerf et al, 1995; Rechter et al, 1999). CTAP-III is a
member of the C-X-C chemokine subfamily (Lida,
1996). CTAP-III has been shown to have various
activities, such as induction of plasminogen activator
activity (Castor et al, 1990) and stimulation of hista-
mine release from basophils (Baeza et al, 1990).
CTAP-III has also been detected in wound fluid (Mat-
suoka and Grotendorst, 1989) and the sera of rheuma-
toid arthritis patients (Castor et al, 1993), therefore
CTAP-III may serve as mediator of inflammation. In
addition to these characteristics, CTAP-III derived
from platelets (Hoogewerf et al, 1995), as well as T
cells and neutrophils (Rechter et al, 1999), exhibits
heparanase activity at slightly acidic pH conditions,
similar to the lower-pH-dependency for placental
heparanase activity (Gilat et al, 1995). Together, these
findings support the idea that CTAP-III may function
as at least one of the heparanases that facilitate
immune cell migration into ECM during inflamma-
tion. Enzymes, such as CTAP-III, that are released by
immune cells in the context of ECM may serve as
utility factors with multiple capacities to modify the
environment and modulate inflammatory-cell behav-
ior.
The enzymatic cleavage of the ECM probably cre-
ates a path through the matrix for leukocyte migra-
tion. During this process, resultant degradation
products are released into the inflammation milieu.
Recently, we have found that heparanase degradation
of HS moieties in the ECM produces molecules that
can affect inflammatory processes. Such
ECM-derived products were found to be tri-sulfated
disaccharides. Derivatives of heparin, a molecule
chemically-related to HS glycosaminoglycans, pro-
duced by the action of heparinase yields disaccharides
with activities similar to disaccharides derived from
ECM. These disaccharides were shown to suppress in
vivo T cell-mediated delayed-type hypersensitivity
reaction (Lider et al, 1995) and arrested the progres-
sion of adjuvant arthritis in rats (Cahalon et al, 1997).
Moreover, these disaccharides were shown to reduce
the activity of TNFc secreted from various in vitro
stimulated immune cells, such as T cells, macro-
phages, and mast cells (Lider et al, 1995; Cahalon et
al, 1997).
Since the disaccharides were derived from the
ECM environment through which immune cells
adhere and migrate, the disaccharides’ effects on T
cell adhesion to ECM substrates were analyzed.
Treatment of T cells with heparan sulfate and heparin
derived disaccharides stimulated T cell adhesion to
endothelial cells, ECM, and fibronectin (unpublished
observations). The adhesion induced by disaccharides
involves specific integrins of the [1 sub-family and is
targeted to the RGD sequence on FN. Moreover, the
disaccharide-induced adhesion of T cells involves T
cell-expressed G protein-coupled receptors and a cas-
cade of events in which the signaling of protein
kinase C plays a role. The up-regulation of T cell
integrin affinities by disaccharides can be considered
an active process that is mediated through diverse
intracellular signaling pathways, rather than a passive
interruption to T cell-substrate interactions. Interest-
ingly, the adhesion ofT cells to fibronectin was inhib-
ited when these cells were exposed to the
disaccharides, together with distinct accessory mole-
cules in the same environment. These accessory sig-
nals were found to be chemokines such as MIP-I
and RANTES, but not other pro-adhesive stimuli,232 HAGAI SCHOR et al.
(IL-2, PHA or CD3 cross-linking; Hershkoviz et al,
2000). Similar to their anti-adhesive effects, the disac-
charides inhibited MIP-l-induced T cell chemotaxis
through FN-coated polycarbonate filter membranes in
trans-well migration assays. Thus, ECM-derived dis-
accharides appear to inhibit T cell adhesion and
migration induced by chemokines, since they did not
inhibit T cell integrin-mediated adhesion induced by
non-chemokine activators.
The mechanisms by which heparin- and
HS-derived disaccharides exert their adhesion- and
chemotactic migration-modifying capacities are not
yet fully understood. However, the biological func-
tions of the enzyme-generated disaccharide molecules
were not restricted to their induction of activation of
T cell adhesion. Disaccharide compounds inhibited T
cell migration specifically induced by chemokines. It
has been reported that down-regulation of the func-
tion of chemokine receptors on leukocytes may result
from de-sensitization of chemokine-specific receptors
occurring from changes in phosphorylation of the
intracellular domain of the receptor (Ben-Baruch et
al, 1997). These findings support a mechanism by
which disaccharide molecules can exert their inhibi-
tion of chemokine-fiaediated processes via certain
active mechanisms, namely, the desensitization of
specific chemokine receptors. Such moieties of
heparin and HS proteoglycans, its related molecules,
or other ECM byproducts generated by enzymatic
action may inherently affect cell behavior by exerting
antiinflammatory properties, representing yet another
fundamental loop in the regulation of inflammatory
events.
B. Urokinase plasminogen activator
Plasminogen activator (PA) and its specific inhibitors
(PAIs) have a central role in the enzymatic cascades
which govern matrix production, remodeling, and
turnover. These enzymatic cascades involve interac-
tions of PA, MMPs and other serine proteinases that
may yield activation of one another’s zymogens
(Blasi, 1997; Vassalli et al, 1991). Active uPA derived
from pro-uPA, binds to its membrane receptor
uPA-receptor (uPAR) and stimulates the proteolytic
activity. The proteolysis is modulated by the binding
of PAIs to this complex. The active uPA preferentially
cleaves plasminogen-zymogen and activates the gen-
eration of plasmin. Plasmin, a serine protease, is sig-
nificant for fibrinolysis and ECM renovation
processes. The ECM interactions with components of
this cascade emphasize its importance in inflammation.
Associations of PA and PAI with heparin
(Andrade-Gordon et al, 1986) and PAI- and uPAR-vit-
ronectin interaction (Blasi, 1997) have been described.
These interactions highlight the importance of ECM
components in promoting activation and de-activation
of uPA-mediated proteolysis by sequestering these
molecules and providing substrates for cell adhesion.
Upon dissociation of PAI from the uPA-uPAR-com-
plex, uPA-mediated cleavage takes place, and plas-
minogen, which is found in fibrin clots or bound to its
cell surface receptor, is converted to active plasmin
(Vassalli et al, 1991). The interaction of the cascade
components with cell and ECM substrates in the
vicinity of the enzymatic action restricts and localizes
the process, and thus enables proper migration toward
the inflamed site. Moreover, uPA-uPAR binding can
induce exposure of a chemotactic epitope and stimu-
late chemotaxis of activated leukocytes (Fazioli,
1997; Hoyer-Hansen, 1997). Thus, uPA binding to
uPAR can affect local proteolytic or chemotactic
capabilities of cells within the inflammatory milieu.
Several lines of evidence have clarified the signifi-
cance of the uPA system in T lymphocyte functions
during inflammation. Binding of uPA-uPAR facili-
tates invasion into a fibrin matrix by Jurkat T lym-
phoma cells (Kramer et al, 1994) and activation of
peripheral blood T lymphocytes both in vivo and in
vitro (Nykjaer et al, 1996). In addition, PMA stimu-
lated HUT 78 lymphoid cells secrete a modulator that
induces uPA activity (Osada et al, 1996). T cells,
derived from an HIV-positive donor, express high lev-
els of uPAR. Yet, healthy donor T cell-expression is
amplified by in vitro stimulation with phorbol ester,
mitogens, cytokines (IL-2, IL-4, IL-7) and upon
co-clustering of the TCR complex and integrins via
treatment with specific antibodies (Bianchi et al,
1996). Subsequently, plasminogen activation by these
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et al, 1994). Degradation of tenascin C, an anti-adhe-
sive ECM protein, by plasmin converts the ECM pro-
tein from anti- to pro-adhesive for lymphocytes.
Thus, ECM cleavage by migrating cells may yield
potent factors that affect cell behavior and cell-matrix
interactions.
C. Matrix metalloproteinases (MMPs) interactions
with the ECM
Migrating leukocytes express MMPs to facilitate
movement across tissue barriers. Leukocytes rely on
these enzymes to mediate their extravasation and pen-
etration into tissues during inflammation (Owen and
Campbell, 1999; Goetzl et al, 1966; Woessner, 1991).
The MMP family of enzymes shares a common struc-
tural domain and can collectively cleave every ECM
substrate (Woessner, 1991). MMP zymogens are acti-
vated by the action of plasmin or other enzymatic or
chemical mechanisms, as well as by other activated
MMPs, by exposing an intrinsic zinc ion that is essen-
tial for their activity. MMP activities are restrained
and regulated by various inhibitors, particularly the
family of endogenous tissue inhibitors of metallopro-
teinases (TIMPs). TIMPg exert their activity by bind-
ing non-covalently to MMPs (Goetzl et al, 1996), and
have been detected as soluble inhibitors in the body
fluid (TIMP-land TIMP-2), or anchored to the ECM
(TIMP-3). The high abundance of TIMPs in both
body fluids and ECM environment emphasizes the
necessity to modulate MMPs activity. In addition,
MMP expression and secretion is tightly regulated at
the level of gene transcription (Mauviel, 1993).
MMPs involvement has been implicated in normal
tissue remodeling during development, menstruation,
wound repair following tissue injury, as well as in
pathological states, such as metastatic cancer, multi-
ple sclerosis, rheumatoid arthritis, and periodontal
disease(Goetzl et al, 1996; Woessner, 1991; Owen
and Campbell, 1999).
In general, MMPs are synthesized de novo and are
rapidly secreted by migrating leukocytes after stimu-
lation with specific pro-inflammatory inducers, such
as IL-1, TNF(x, PDGF, and prostaglandin E2 (Mau-
viel, 1993; Johnatty et al, 1997; Leppert et al, 1995).
In addition, chemokines, such as RANTES, MIP-lo
and MIP-I induce the expression of MMP-9 (John-
atty et al, 1997). T cell activation by IL-2 greatly aug-
ments MMP-9 and MMP-2 expression, the
predominant MMPs of T cells, and thereby, migration
across gels of basement membrane (Leppert et al,
1995). In contrast, interferon-y, progesterone, and
corticosteroids are among the inflammatory media-
tors which may suppress MMP synthesis (Woessner,
1991; Johnatty et la, 1997). Interestingly, several of
the cytokines and chemokines that modulate the
expression of MMPs and induce adhesion and migra-
tion of T cells, are anchored to ECM moieties. Thus,
these mediators may have a profound impact on cell
migration since they affect both cell adhesion and
influence MMPs synthesis. Moreover, adhesion of
immune cells by itself can induce VCAM-1 mediated
expression of 72-kDa gelatinase (Romanic and Madri,
1994), and cell-matrix interactions via 131 integrins
control MMP-dependent migration through basement
membrane (Xia et la, 1996). Therefore, MMPs
expression is regulated by several mechanisms that
modulate their activity during cell extravasation from
the blood and migration through inflamed tissues.
MMP interactions with and disruption ofECM pro-
teins may result in the release of growth factors and
inflammatory mediators bound and sequestered in the
context of migration through matrix (Imai et al,
1997). The same cytokines that can induce metallo-
proteinase production may also be substrates for
cleavage by MMPs. For example, MMPs are capable
of processing and inactivating the proinflammatory
cytokine IL-I (Ito et al, 1996), while the release of
membrane-bound TNFc (McGeehan et al, 1994) aug-
ments and sustains inflammation. Therefore, MMPs
may either promote the activity of pro-inflammatory
signals or reduce their impact. Together, these find-
ings emphasize the important role of MMPs in regu-
lating inflammatory responses by not only clearing a
path for migrating cells, but also modulating the con-
textual signals that affect immune cell activity.234 HAGAI SCHOR et al.
D. Elastase, more than a ECM degrading enzyme
Human leukocyte elastase (HLE) is a serine protein-
ase that degrades various matrix substrates, such as
elastin, collagen, fibronectin, and HS proteoglycans.
HLE and its catalytic activity depend on an intrinsic
serine residue in its active site. Various cell types
secrete elastase, including macrophages, neutrophils,
and T cells (Bieth, 1986). Elastase has been shown to
be important in several biological process, such as
induction of cytokine secretion (Bedard et al, 1993),
cell activation (Renesto and Ghignard, 1993), and
degradation of clotting factors (Taylor et al, 1977).
Moreover, elastase can degrade and release surface
molecules, such as CD2, CD4, and CD8, from T cell
surface and therefore, affect their physiology in
inflammatory diseases (Doring et al 1995). Binding of
elastase to neutrophils and monocytes can regulate
the avidity and pro-adhesiveness of the integrin
MAC-1 (CDllb/CD18) (Cai and Wright 1996).
Elastase is a potent enzyme that possesses immense
proteolytic and destructive potential. It is stored in its
active form within leukocyte granules (Gallin, 1984).
Therefore, there is a necessity to restrict and tightly
regulate elastase activity. Indeed, this necessity is ful-
filled by natural inhibitors of serine proteinases,
termed serpins, which actually comprise about 10%
of total plasma proteins. Upon cellular activation by
TNFc and IL-8, HLE is translocated to the plasma
membrane. This mechanism ensures a focused locali-
zation of the enzymes’ biological activities within
specific proximity (Owen et al, 1997). Both soluble
and membrane-bound forms of elastase are synthe-
sized by T cells (Bristow et al, 1991). HLE is predom-
inantly synthesized by neutrophils, yet, T cell
elastase, in moderate levels, can make contributions
in modifying cell-matrix interactions, ECM moieties,
and cytokine activities as needed during inflamma-
tory episodes. Moreover, the release of elastase from
T cells in moderation may actually be a mode of pre-
venting dysregulated proteolysis.
In addition its ECM degrading activity, elastase
may be involve in the cleavage of inflammatory
cytokines and their receptors (Porteu et al, 1991), and
therefore modify their action. The elastase-mediated
cytokine-modification may enhance cytokine activity,
as was shown for IL-8 and IL-1 (Black et al, 1991;
Padrines et al, 1994), or may inactivate it (Scuderi et
al, 1991). A recent study in our laboratory suggested
that elastase cleaves IL-2, a pro-inflammatory
cytokine and chemoattractant, to produce peptides
with a regulatory functions. These IL-2 peptides have
been shown to inhibit T-cell migration through
FN-coated membranes induced by IL-2 and MIP-I[
as well as to inhibit T-cell adhesion to FN induced by
IL-2, IL-7, MIP-I[, PMA, anti-CD3, and
anti-ll-integrin-activating mAb. Thus, the enzymatic
products of IL-2 may serve as natural inhibitors of
inflammation (Ariel et al, 1998). Consequently, HLE
may coordinate the performance of inflammatory
mediators, such as cytokines, by generating either
active or inactive forms to contribute in regulating the
inflammatory response.
ECM DEGRADATION YIELDS A NEW
CONTEXT WITH NOVEL SIGNALS
Immune cells adapt their behavior according to con-
textual information introduced to them by the con-
stantly changing environment of the ECM. Thus,
alteration of ECM consonance may transduce novel
regulatory signals that are important for cell adapta-
tion to a new environment (Lukashev and Werb,
1998). During inflammation, there are changes in the
equilibrium between ECM constituents, such as FN,
collagen, and HS proteoglycans, as well as introduc-
tion of new adhesion molecules which are not usually
abundant in ECM (Clark, 1996; Guadiz et al, 1997).
ECM degradation products may also have regulatory
properties. For example, chemotactic FN fragments
may selectively attract monocytes and other leuko-
cytes into inflamed tissue (McDonald and Kelley,
1980; Norris et al, 1982). Fragments of laminin (Tan-
aka et al, 1997), collagen type IV (Nakagawa et al,
1999), and fibrin (Gray et al, 1995) also exhibit regu-
latory roles in immune cell migration and prolifera-
tion during inflammatory processes. The notion that
tissue-degrading enzymes secreted by leukocytes and
other cells in the inflammatory milieu can modifyINFLAMMATORY ENVIRONMENT MODULATES LYMPHOCYTE BEHAVIOR 235
immune cell functions by altering the ECM context
and producing small signalling molecules further
highlight the importance of matrix-degrading
enzymes in inflammatory processes.
CONCLUDING REMARKS
The inflammatory microenvironment continuously
and dynamically changes, enabling extravasating leu-
kocytes to communicate with their surroundings, pro-
duce signals, and function immunologically. The
ECM can be considered a physical barrier, and it has a
multifactorial regulatory role in the inflammatory
process. Specifically, the ECM provides cells with
immunological information by sending regulatory
messages that enable them to constantly adapt and
fine-tune their responses and activities, in accordance
with their varied surroundings (Loike et al, 1995).
Moreover, the ECM can make contact with the
migrating cells in its "activated" form, which facili-
tates proinflammatory processes, such as cell migra-
tion and recruitment. However, activated leukocytes
and other cells that constitute the dynamic microenvi-
ronment are also capabl’e of affecting their surround-
ings. These cells release a wide range of cytokines,
chemokines, growth factors, and other inflammatory
mediators, together with matrix-degrading enzymes,
into the inflammatory milieu. As a consequence,
immune cells are able to modulate their own environ-
ment. The modulated ECM begins to function in reg-
ulatory feedback activities upon the initial immune
reaction. We propose, from the line of evidence we
have discussed in this review, that immune cells have
sensory mechanisms that enable them to process and
cognitively interpret the input data from the modified
environments, then correctly resolve the output
responses. These cellular sensory systems utilize
membrane receptors, including chemokine, cytokine,
and adhesion receptors, which are molecules that par-
ticipate in intercellular and cell-tissue interactions.
The real-time sensing and processing ability of the
immune system enables it to respond to a specific
antigen and "cognitively" modify its activity in
response to changing contextual information.
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